Notice: Holiday Sample Receiving Hours for 2026 Mid-Autumn Festival
World-Leading
CTC Expansion Technology
Driven by Cellular Insights, Empowering Precision Medical Decisions.
COMPANY OVERVIEW
About MEXOCELL
Precision
Driven by Cellular Insights, Empowering Precision Medical Decisions
MEXOCELL is dedicated to advancing precision medicine and cell technology innovation, specializing in circulating tumor cell (CTC) and immune cell detection technologies. Through our proprietary R&D platform, we deliver highly accurate and real-time solutions for disease risk assessment and treatment monitoring. We believe that the future of healthcare extends beyond treating disease—it lies in leveraging cellular-level insights to enable early prediction, precision intervention, and continuous health tracking.
Learn more
01
02
ANNOUNCEMENTS & UPDATES
NEWS
Core Technologies
- 01Proprietary TechnologyWorld's first simultaneous expansion of conventional CTCs and rare CHCs
- 02Overcoming LimitationsSufficient cell yield bypasses the constraints of organoid models
- 03Patented Cell CultureBypasses cumbersome isolation and culturing bottlenecks
- 04Avatars for Personalized MedicineTailored, large-scale drug screening for individuals
- 05Comprehensive PlatformPersonalized solutions for clinicians, preventive healthcare, and pharmaceutical companies
- 06Versatile ApplicationsCovers immunology, oncology, and stem cell testing
- 07Rapid TurnaroundFast-track reporting delivered within 14 business days
